Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry).

[1]  A. Colombo,et al.  Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment , 2007, Circulation.

[2]  C. Di Mario,et al.  Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study. , 2007, International journal of cardiology.

[3]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[4]  B. Xu,et al.  Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent. , 2007, Chinese medical journal.

[5]  P. Serruys,et al.  Two‐year clinical outcome after coronary stenting of small vessels using 2.25‐mm sirolimus‐ and paclitaxel‐eluting stents: Insight into the RESEARCH and T‐SEARCH registries , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  A. Kastrati,et al.  Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. , 2006, Journal of the American College of Cardiology.

[7]  Seung‐Jung Park,et al.  Comparison of the effectiveness of sirolimus‐ and paclitaxel‐eluting stents for small coronary artery lesions , 2006, Catheterization and cardiovascular interventions.

[8]  A. Kastrati,et al.  Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. , 2006, European heart journal.

[9]  M. Valdés,et al.  Early results of direct coronary stenting in consecutive patients when multivessel, complex, long lesions, and small vessels are included. , 2005, International journal of cardiology.

[10]  Gregg W Stone,et al.  Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. , 2005, JAMA.

[11]  P. Serruys,et al.  Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. , 2005, European heart journal.

[12]  E. Bramucci,et al.  Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. , 2004, JAMA.

[13]  J. Popma,et al.  The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). , 2004, Journal of the American College of Cardiology.

[14]  G. Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.

[15]  William Wijns,et al.  Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.

[16]  A. Kastrati,et al.  Stenting for small coronary vessels: a contestable winner. , 2001, Journal of the American College of Cardiology.

[17]  A. Kastrati,et al.  A Randomized Trial Comparing Stenting With Balloon Angioplasty in Small Vessels in Patients With Symptomatic Coronary Artery Disease , 2000 .

[18]  Y. Lim,et al.  Stent placement for non‐STRESS/BENESTENT lesions: A critical review , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  G. Stone,et al.  Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.